Literature DB >> 22056711

[Effectiveness of systemic chemotherapy of GEM+CBDCA+5-FU/LV and hepatic arterial infusion of CDDP in a case of advanced, combined hepatocellular-cholangiocarcinoma with multiple lung metastases].

Satoshi Tani1, Shigemasa Murata, Miho Tamura, Kaoru Fukunaga, Munetaka Morita, Yuzo Hirata, Hiroya Iida, Ayako Kakuno, Takashi Nishigami, Naoki Yamanaka.   

Abstract

This patient is a male in his 30's. He was diagnosed as hepatitis B virus-related huge primary liver cancer, 10cm in diameter, located in segment 4, accompanied with left portal thrombus and multiple lung metastases. Ten months after repeating systemic chemotherapy using gemcitabine (GEM)+carboplatin (CBDCA)+5-FU/leucovorin (LV) and hepatic arterial infusion chemotherapy with cisplatin (CDDP) 4 times, extended left lobectomy with caudate lobe could be successfully performed because of marked reducion of the huge tumor. The pathology revealed almost entirely necrotic changes of the main tumor, and the remaining, viable tumor nests showed combined hepatocellular and cholangiocarcinoma. Systemic chemotherapy was repeatedly given afterwards, which kept the pulmonary metastases stable without growth. The present case suggests that systemic chemotherapy using GEM+CBDCA+5-FU/LV may be useful in the multimodal treatment for the combined hepatocellular and cholangiocarcinoma with distant metastases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056711

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  3 in total

1.  Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review.

Authors:  Ming Chi; Kaidi Mikhitarian; Chanjuan Shi; Laura W Goff
Journal:  Gastrointest Cancer Res       Date:  2012-11

2.  Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma.

Authors:  Satoshi Kobayashi; Takeshi Terashima; Satoshi Shiba; Yukio Yoshida; Ikuhiro Yamada; Shouta Iwadou; Shigeru Horiguchi; Hideaki Takahashi; Eiichiro Suzuki; Michihisa Moriguchi; Kunihiro Tsuji; Taiga Otsuka; Akinori Asagi; Yasushi Kojima; Ryoji Takada; Chigusa Morizane; Nobumasa Mizuno; Masafumi Ikeda; Makoto Ueno; Junji Furuse
Journal:  Cancer Sci       Date:  2018-06-27       Impact factor: 6.716

Review 3.  Therapy of Primary Liver Cancer.

Authors:  Mei Feng; Yisheng Pan; Ruirui Kong; Shaokun Shu
Journal:  Innovation (Camb)       Date:  2020-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.